24 May 2013
Keywords: gsk, gets, ok, return, lotronex, irritable, bowel
Article | 17 June 2002
GlaxoSmithKline has been given the go-ahead by the US Food and DrugAdministration to re-introduce its irritable bowel syndrome drug
Lotronex ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 June 2002
10 June 2002
23 May 2013
© 2013 thepharmaletter.com